Abstract

A REVIEW ON IMPACT OF MENTAL HEALTH ISSUES BURDEN AND ITS THERAPEUTIC STRATEGIES IN COPD PATIENTS

Maneesha Annavarapu*, Tahera Mubeen, Naveen Yaradesi and Padmalatha Kantamneni

Abstract

Chronic obstructive pulmonary disease (COPD) is described by chronic airflow restriction induced by an overactive inflammatory response in the lungs and partially reversible symptoms. People with the chronic obstructive pulmonary disease face a significant challenge, which may include a variety of symptoms (breathlessness, cough, sputum production, wheezing, and chest tightness) of varying severity. COPD patients also experience psychiatric comorbidities. Anxiety and/or depression have been related to an increased risk of death, exacerbation rates, hospitalization duration, and a lower quality of life and functional status in COPD patients. Comorbid depression is common in COPD patients and is linked to a worsening of the disease's course. Despite its negative consequences, depression and anxiety are frequently undiagnosed and untreated in COPD patients. There is no consensus on the best way to screen COPD patients for anxiety and depression. The treatment strategies include behavioral and pharmacological approaches and more high-quality trials are required to improve the screening and treatment of anxiety and depression in COPD patients, as well as their complex chronic condition management. The findings of this narrative analysis, which primarily focus on clinical data in COPD patients in various locations, indicate that improved knowledge and recognition are needed to alleviate this burden.

Keywords: Mental health issues, anxiety, Depression, Mechanisms, Therapeutic options.